Skip to main content

Table 2 Risk factors for the development of invasive candidal infection

From: Prediction of invasive candidal infection in critically ill patients with severeacute pancreatitis

  Patients without invasive candidal infection Patients with invasive candidal infection P value
Patients, number 83 18  
Severe sepsis on admission to ICU, number (%) 30 (36.1) 7 (38.9) 0.999
CVC, number (%) 74 (89.2) 17 (94.4) 0.686
Antibiotics, number (%) 53 (63.9) 14 (77.8) 0.409
Renal replacement therapy, number (%) 14 (16.9) 4 (22.2) 0.734
Steroids, number (%) 34 (41) 7 (38.9) 0.999
Immunosuppressive drugs, number (%) 2 (2.4) 2 (11.1) 0.145
Surgery, number (%) 22 (26.5) 7 (38.9) 0.389
TPN, number (%) 26 (31.3) 8 (44.4) 0.288
Significant pancreatic necrosis, number (%) 40 (48.2) 13 (72.2) 0.063
Positive blood culture, number (%) 28 (33.7) 8 (44.4) 0.424
Colonised with candida, number (%) 37 (44.6) 16 (88.9) >0.001
  1. CVC, central venous catheter; ICU, Intensive Care Unit; TPN, total parenteralnutrition.